Paula Chatterjee

Oct 29, 2024 | acpjournals.org | Paula Chatterjee

Medicare beneficiaries face substantial cost sharing for most inpatient care, outpatient services, and prescription drugs. Nationally, 36% of beneficiaries report difficulty paying medical bills or delaying care due to cost concerns, and those with multiple chronic conditions and serious illnesses are at particular risk for high out-of-pocket costs and economic hardship (1). Supplemental insurance through Medicaid or private plans can shield individuals from these costs (2–6).

Oct 18, 2024 | jamanetwork.com | Matthew J. Klebanoff |Paula Chatterjee

Introduction Real-time prescription benefit tools (RTBTs) display out-of-pocket drug cost estimates in the electronic health record (EHR) at the point of prescribing.1 RTBTs can help lower out-of-pocket drug spending.2 Since 2021, the Centers for Medicare & Medicaid Services have required Part D plan sponsors to implement RTBTs that can be incorporated into EHRs.3 However, health care facilities are not mandated to adopt RTBTs. Hospitals that serve patients who are economically and socially...

Sep 18, 2024 | ldi.upenn.edu | Paula Chatterjee

Diversifying clinical trial participation is a national priority. Federal research institutions, regulators, and Congress have called for efforts to include historically underrepresented populations in clinical studies. Yet ensuring diversity in clinical trials remains challenging for several reasons including limited trust in the health care system, barriers to access, and the financial burden of participating in clinical trials. One potential fix may actually lie where few have looked: Medicaid.